Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SORE THROAT 15-3.6 MG LOZENGE

Benzocaine and Menthol
$0.1477per EA
OTC

Strength

15; 3.6 mg/1; mg/1

Manufacturer

Major Pharmaceuticals

NDC

00904625549

Classification

Generic

Dosage Form

LOZENGE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

BENZOCAINE; MENTHOL

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

12/28/2012

Pharmacological Classes

Allergens
Cell-mediated Immunity
Increased Histamine Release
Standardized Chemical Allergen

Price History

1W

0.0%

1M

-0.2%

3M

-0.5%

6M

-2.8%

1Y

-5.4%

3Y

+64.0%

5Y

+47.9%

All

+62.7%

Generic Alternatives

1 alternative • Same active ingredient

CEPACOL SORE THROAT LOZENGE
Brand
63824071316•RB Health (US) LLC
$0.1484
+0% more

Related Drugs

Same classification

GS HEMORRHOIDAL CREAM
Generic
00113094424•L. Perrigo Company
$0.0451
per GM
HEMORRHOIDAL CREAM
Generic
36800094424•Topco Associates LLC
$0.0469
per GM
GLYCERIN SUPPOSITORY
Generic
46122022171•AmerisourceBergen
$0.0689
per EA
HEMORRHOIDAL CREAM
Generic
70000042501•Cardinal Health
$0.0796
per GM
GNP REDNESS RELIEF EYE DROPS
Generic
46122060605•AmerisourceBergen
$0.0947
per ML
REDNESS RELIEF EYE DROPS
Generic
70000001001•Cardinal Health
$0.0947
per ML
FT REDNESS RELIEF EYE DROPS
Generic
70677116101•Strategic Sourcing Services LLC
$0.0947
per ML
GLYCERIN SUPPOSITORY
Generic
46122022163•AmerisourceBergen
$0.1099
per EA
GLYCERIN 2 GM SUPPOSITORY
Generic
57237032552•Rising Pharma Holdings Inc.
$0.1099
per EA
GLYCERIN ADULT SUPPOSITORY
Generic
70000057201•Cardinal Health
$0.1099
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy